Loading
PDBj
English日本語简体中文繁體中文한국어
✖
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
Search by PDB author
7ND7
DownloadVisualize
BU of 7nd7 by Molmil
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab
Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ...
Authors:Duyvesteyn, H.M.E, Zhao, Y, Ren, J, Stuart, D.
Deposit date:2021-01-30
Release date:2021-03-03
Last modified:2021-04-28
Method:ELECTRON MICROSCOPY (3.6 Å)
Cite:The antigenic anatomy of SARS-CoV-2 receptor binding domain.
Cell, 184, 2021
7ND9
DownloadVisualize
BU of 7nd9 by Molmil
EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-253H55L Fab
Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ...
Authors:Duyvesteyn, H.M.E, Zhao, Y, Ren, J, Stuart, D.
Deposit date:2021-01-30
Release date:2021-03-03
Last modified:2021-04-28
Method:ELECTRON MICROSCOPY (2.8 Å)
Cite:The antigenic anatomy of SARS-CoV-2 receptor binding domain.
Cell, 184, 2021
7NDD
DownloadVisualize
BU of 7ndd by Molmil
EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-159
Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, COVOX-159 Fab heavy chain, ...
Authors:Duyvesteyn, H.M.E, Zhao, Y, Ren, J, Stuart, D.
Deposit date:2021-01-30
Release date:2021-03-03
Last modified:2021-04-28
Method:ELECTRON MICROSCOPY (4.2 Å)
Cite:The antigenic anatomy of SARS-CoV-2 receptor binding domain.
Cell, 184, 2021
7NDA
DownloadVisualize
BU of 7nda by Molmil
EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-253H55L Fab
Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ...
Authors:Duyvesteyn, H.M.E, Zhao, Y, Ren, J, Stuart, D.
Deposit date:2021-01-30
Release date:2021-03-03
Last modified:2021-04-28
Method:ELECTRON MICROSCOPY (3.3 Å)
Cite:The antigenic anatomy of SARS-CoV-2 receptor binding domain.
Cell, 184, 2021
7ND5
DownloadVisualize
BU of 7nd5 by Molmil
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab
Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, COVOX-150 Fab heavy chain, ...
Authors:Duyvesteyn, H.M.E, Zhao, Y, Ren, J, Stuart, D.
Deposit date:2021-01-30
Release date:2021-03-03
Last modified:2021-04-28
Method:ELECTRON MICROSCOPY (3.4 Å)
Cite:The antigenic anatomy of SARS-CoV-2 receptor binding domain.
Cell, 184, 2021
7ND6
DownloadVisualize
BU of 7nd6 by Molmil
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab
Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, COVOX-158 Fab heavy chain, ...
Authors:Duyvesteyn, H.M.E, Zhao, Y, Ren, J, Stuart, D.
Deposit date:2021-01-30
Release date:2021-03-03
Last modified:2021-04-28
Method:ELECTRON MICROSCOPY (7.3 Å)
Cite:The antigenic anatomy of SARS-CoV-2 receptor binding domain.
Cell, 184, 2021
7NDB
DownloadVisualize
BU of 7ndb by Molmil
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-253H165L Fab
Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ...
Authors:Duyvesteyn, H.M.E, Zhao, Y, Ren, J, Stuart, D.
Deposit date:2021-01-30
Release date:2021-03-03
Last modified:2021-04-28
Method:ELECTRON MICROSCOPY (4.6 Å)
Cite:The antigenic anatomy of SARS-CoV-2 receptor binding domain.
Cell, 184, 2021
6THK
DownloadVisualize
BU of 6thk by Molmil
Structural mechanism of pyocin S5 import into Pseudomonas aeruginosa
Descriptor: GLYCEROL, Pyocin S5, ZINC ION
Authors:Behrens, H.M, Kleanthous, C, Lowe, E.D.
Deposit date:2019-11-20
Release date:2020-03-04
Last modified:2024-05-15
Method:X-RAY DIFFRACTION (2.2 Å)
Cite:Pyocin S5 Import into Pseudomonas aeruginosa Reveals a Generic Mode of Bacteriocin Transport.
Mbio, 11, 2020
7BEM
DownloadVisualize
BU of 7bem by Molmil
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 scFv
Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, CHLORIDE ION, COVOX-269 Vh domain, ...
Authors:Zhou, D, Zhao, Y, Ren, J, Stuart, D.
Deposit date:2020-12-24
Release date:2021-03-03
Last modified:2024-01-31
Method:X-RAY DIFFRACTION (2.52 Å)
Cite:The antigenic anatomy of SARS-CoV-2 receptor binding domain.
Cell, 184, 2021
7BEH
DownloadVisualize
BU of 7beh by Molmil
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab
Descriptor: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, COVOX-316 heavy chain, ...
Authors:Zhou, D, Zhao, Y, Ren, J, Stuart, D.
Deposit date:2020-12-23
Release date:2021-03-03
Last modified:2024-01-31
Method:X-RAY DIFFRACTION (2.3 Å)
Cite:The antigenic anatomy of SARS-CoV-2 receptor binding domain.
Cell, 184, 2021
7BEN
DownloadVisualize
BU of 7ben by Molmil
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-253 and COVOX-75 Fabs
Descriptor: 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, BROMIDE ION, ...
Authors:Zhou, D, Zhao, Y, Ren, J, Stuart, D.
Deposit date:2020-12-24
Release date:2021-03-03
Last modified:2024-01-31
Method:X-RAY DIFFRACTION (2.5 Å)
Cite:The antigenic anatomy of SARS-CoV-2 receptor binding domain.
Cell, 184, 2021
7BEK
DownloadVisualize
BU of 7bek by Molmil
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-158 Fab (crystal form 2)
Descriptor: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, CHLORIDE ION, ...
Authors:Zhou, D, Zhao, Y, Ren, J, Stuart, D.
Deposit date:2020-12-23
Release date:2021-03-03
Last modified:2024-01-31
Method:X-RAY DIFFRACTION (2.04 Å)
Cite:The antigenic anatomy of SARS-CoV-2 receptor binding domain.
Cell, 184, 2021
7BEO
DownloadVisualize
BU of 7beo by Molmil
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-253H55L and COVOX-75 Fabs
Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ACETATE ION, ...
Authors:Zhou, D, Zhao, Y, Ren, J, Stuart, D.
Deposit date:2020-12-24
Release date:2021-03-03
Last modified:2024-01-31
Method:X-RAY DIFFRACTION (3.19 Å)
Cite:The antigenic anatomy of SARS-CoV-2 receptor binding domain.
Cell, 184, 2021
7BEP
DownloadVisualize
BU of 7bep by Molmil
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-384 and S309 Fabs
Descriptor: CHLORIDE ION, COVOX-384 heavy chain, COVOX-384 light chain, ...
Authors:Zhou, D, Zhao, Y, Ren, J, Stuart, D.
Deposit date:2020-12-24
Release date:2021-03-03
Last modified:2024-01-31
Method:X-RAY DIFFRACTION (2.61 Å)
Cite:The antigenic anatomy of SARS-CoV-2 receptor binding domain.
Cell, 184, 2021
7BEI
DownloadVisualize
BU of 7bei by Molmil
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab
Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, CHLORIDE ION, COVOX-150 heavy chain, ...
Authors:Zhou, D, Zhao, Y, Ren, J, Stuart, D.
Deposit date:2020-12-23
Release date:2021-03-03
Last modified:2024-01-31
Method:X-RAY DIFFRACTION (2.3 Å)
Cite:The antigenic anatomy of SARS-CoV-2 receptor binding domain.
Cell, 184, 2021
7BEL
DownloadVisualize
BU of 7bel by Molmil
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-88 and COVOX-45 Fabs
Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, ACETATE ION, COVOX-45 heavy chain, ...
Authors:Zhou, D, Zhao, Y, Ren, J, Stuart, D.
Deposit date:2020-12-23
Release date:2021-03-03
Last modified:2024-01-31
Method:X-RAY DIFFRACTION (2.53 Å)
Cite:The antigenic anatomy of SARS-CoV-2 receptor binding domain.
Cell, 184, 2021
7BEJ
DownloadVisualize
BU of 7bej by Molmil
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-158 Fab (crystal form 1)
Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, COVOX-158 heavy chain, COVOX-158 light chain, ...
Authors:Zhou, D, Zhao, Y, Ren, J, Stuart, D.
Deposit date:2020-12-23
Release date:2021-03-03
Last modified:2024-01-31
Method:X-RAY DIFFRACTION (2.42 Å)
Cite:The antigenic anatomy of SARS-CoV-2 receptor binding domain.
Cell, 184, 2021
6TCZ
DownloadVisualize
BU of 6tcz by Molmil
Leishmania tarentolae proteasome 20S subunit complexed with LXE408
Descriptor: Proteasome endopeptidase complex, Proteasome subunit alpha type, Proteasome subunit beta, ...
Authors:Srinivas, H.
Deposit date:2019-11-07
Release date:2020-08-26
Last modified:2024-05-22
Method:ELECTRON MICROSCOPY (3.4 Å)
Cite:Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases.
J.Med.Chem., 63, 2020
6TD5
DownloadVisualize
BU of 6td5 by Molmil
Leishmania tarentolae proteasome 20S subunit complexed with LXE408 and bortezomib
Descriptor: N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE, Proteasome endopeptidase complex, Proteasome subunit alpha type, ...
Authors:Srinivas, H.
Deposit date:2019-11-07
Release date:2020-08-26
Last modified:2020-10-21
Method:ELECTRON MICROSCOPY (3.2 Å)
Cite:Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases.
J.Med.Chem., 63, 2020
5VO4
DownloadVisualize
BU of 5vo4 by Molmil
Crystal Structure Of The Androgen Receptor Ligand Binding Domain In Complex With 5-(2-fluoro-4-hydroxyphenyl)-1-methyl-1H-pyrrole-2-carbonitrile
Descriptor: 5-(2-fluoro-4-hydroxyphenyl)-1-methyl-1H-pyrrole-2-carbonitrile, Androgen receptor
Authors:Parris, K, Unwalla, R.
Deposit date:2017-05-02
Release date:2018-03-14
Last modified:2024-03-13
Method:X-RAY DIFFRACTION (2.35 Å)
Cite:Structure-Based Approach To Identify 5-[4-Hydroxyphenyl]pyrrole-2-carbonitrile Derivatives as Potent and Tissue Selective Androgen Receptor Modulators.
J. Med. Chem., 60, 2017
4AA4
DownloadVisualize
BU of 4aa4 by Molmil
P38ALPHA MAP KINASE BOUND TO CMPD 22
Descriptor: MITOGEN-ACTIVATED PROTEIN KINASE 14, N-[4-METHYL-3-[6-(4-METHYLPIPERAZIN-1-YL)-4-OXIDANYLIDENE-QUINAZOLIN-3-YL]PHENYL]FURAN-3-CARBOXAMIDE
Authors:Gerhardt, S, Hargreaves, D.
Deposit date:2011-11-30
Release date:2012-05-16
Last modified:2023-12-20
Method:X-RAY DIFFRACTION (2.3 Å)
Cite:The Discovery of N-Cyclopropyl-4-Methyl-3-[6--(4-Methylpiperazin-1-Yl-4-Oxoquinazolin-3(4H)-Yl]Benzamide (Azd6703), a Clinical P38Alpha Map Kinase Inhibitor for the Treatment of Inflammatory Diseases
Bioorg.Med.Chem.Lett., 22, 2012
4A9Y
DownloadVisualize
BU of 4a9y by Molmil
P38ALPHA MAP KINASE BOUND TO CMPD 8
Descriptor: MITOGEN-ACTIVATED PROTEIN KINASE 14, N-(3-{[7-METHOXY-6-(2-PYRROLIDIN-1-YLETHOXY)QUINAZOLIN-4-YL]AMINO}-4-METHYLPHENYL)-2-MORPHOLIN-4-YLISONICOTINAMIDE
Authors:Gerhardt, S, Hargreaves, D.
Deposit date:2011-11-29
Release date:2012-05-16
Last modified:2024-05-08
Method:X-RAY DIFFRACTION (2.2 Å)
Cite:The Discovery of N-Cyclopropyl-4-Methyl-3-[6--(4-Methylpiperazin-1-Yl-4-Oxoquinazolin-3(4H)-Yl]Benzamide (Azd6703), a Clinical P38Alpha Map Kinase Inhibitor for the Treatment of Inflammatory Diseases
Bioorg.Med.Chem.Lett., 22, 2012
4AA0
DownloadVisualize
BU of 4aa0 by Molmil
P38ALPHA MAP KINASE BOUND TO CMPD 2
Descriptor: MITOGEN-ACTIVATED PROTEIN KINASE 14, N-[4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxidanylidene-quinazolin-3-yl]phenyl]-2-morpholin-4-yl-pyridine-4-carboxamide
Authors:Gerhardt, S, Hargreaves, D.
Deposit date:2011-11-30
Release date:2012-05-16
Last modified:2024-05-08
Method:X-RAY DIFFRACTION (1.8 Å)
Cite:The Discovery of N-Cyclopropyl-4-Methyl-3-[6--(4-Methylpiperazin-1-Yl-4-Oxoquinazolin-3(4H)-Yl]Benzamide (Azd6703), a Clinical P38Alpha Map Kinase Inhibitor for the Treatment of Inflammatory Diseases
Bioorg.Med.Chem.Lett., 22, 2012
4AAC
DownloadVisualize
BU of 4aac by Molmil
P38ALPHA MAP KINASE BOUND TO CMPD 29
Descriptor: CHLORIDE ION, MITOGEN-ACTIVATED PROTEIN KINASE 14, N-isoxazol-3-yl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxo-quinazolin-3-yl]benzamide
Authors:Gerhardt, S, Hargreaves, D.
Deposit date:2011-12-01
Release date:2012-05-16
Last modified:2024-05-08
Method:X-RAY DIFFRACTION (2.5 Å)
Cite:The Discovery of N-Cyclopropyl-4-Methyl-3-[6--(4-Methylpiperazin-1-Yl-4-Oxoquinazolin-3(4H)-Yl]Benzamide (Azd6703), a Clinical P38Alpha Map Kinase Inhibitor for the Treatment of Inflammatory Diseases
Bioorg.Med.Chem.Lett., 22, 2012
4AA5
DownloadVisualize
BU of 4aa5 by Molmil
P38ALPHA MAP KINASE BOUND TO CMPD 33
Descriptor: MITOGEN-ACTIVATED PROTEIN KINASE 14, N-CYCLOPROPYL-4-METHYL-3-[6-(4-METHYLPIPERAZIN-1-YL)-4-OXIDANYLIDENE-QUINAZOLIN-3-YL]BENZAMIDE
Authors:Gerhardt, S, Hargreaves, D.
Deposit date:2011-11-30
Release date:2012-05-16
Last modified:2019-02-06
Method:X-RAY DIFFRACTION (2.38 Å)
Cite:The Discovery of N-Cyclopropyl-4-Methyl-3-[6--(4-Methylpiperazin-1-Yl-4-Oxoquinazolin-3(4H)-Yl]Benzamide (Azd6703), a Clinical P38Alpha Map Kinase Inhibitor for the Treatment of Inflammatory Diseases
Bioorg.Med.Chem.Lett., 22, 2012
<12

 

222624

PDB entries from 2024-07-17

PDB statisticsPDBj update infoContact PDBjnumon